Clover had a write up in Brendan Lau's Small Caps column in last Thursday's AFR.
Main points:
- Some believe CLV is under-appreciated since it is on track to post 60% sales growth in the new financial year.
- CLV has delivered a 39% annual return compared to 11% for the ASX Small Industrial Index.
- CLV has tumbled 11% from Feb's five year high of 32c after its joint venture posted worse than expected losses.
- Healthy balance sheet with $30 million in cash and no debt.
- Microequities is forecasting a 30% lift in net profit to $4.2 million for 2009-10.
- Next year's result could be even better if CLV sold some of its non-core assets.
- Carlos Gil from Microequities believes the outlook for CLV couldn't be brighter with exposure to the fast growing Omega-3 market in particular Asia.
Clover had a write up in Brendan Lau's Small Caps column in last...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CLV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
-0.005(1.01%) |
Mkt cap ! $60.11M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 49.5¢ | 49.0¢ | $8.983K | 18.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32789 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 44797 | 1 |
View Market Depth
| Last trade - 15.45pm 15/11/2024 (20 minute delay) ? |
| CLV (ASX) Chart |
